Provectus Pharmaceuticals


Provectus Pharmaceuticals Stock Quote
$0.06 $0.00 4.0%
BATS BZX Real Time Price as of October 18, 2019, 2:19 p.m. EDT View Interactive PVCT Charts

A development-stage biopharmaceutical company that is focusing on developing minimally invasive products for the treatment of psoriasis and other topical diseases, and certain forms of cancer.

News & Analysis: Provectus Pharmaceuticals


3 Humongous Health-Care Stocks This Week

Which health-care stocks stood out as the most humongous winners this week? Provectus, Inovio, and United Therapeutics take the honors.

Interactive Chart